SHR-1916: A Novel PEGylated Interleukin-2 Analogue with Altered Cellular Selectivity and Improved Pharmacokinetic Profiles for Cancer Immunotherapy
Xianglin Kong,1,2 Yuan Lin,2 Chao Ouyang,2 Hao Chen,2 Xiangdong Gao1 1Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, People’s Republic of China; 2Jian...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2025-02-01
|
| シリーズ: | Drug Design, Development and Therapy |
| 主題: | |
| オンライン･アクセス: | https://www.dovepress.com/shr-1916-a-novel-pegylated-interleukin-2-analogue-with-altered-cellula-peer-reviewed-fulltext-article-DDDT |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|